Brain activity requires a flux of glucose to active regions to sustain increased metabolic demands. Insulin, the main regulator of glucose handling in the body, has been traditionally considered not to intervene in this process. However, we now report that insulin modulates brain glucose metabolism by acting on astrocytes in concert with IGF-I. The cooperation of insulin and IGF-I is needed to recover neuronal activity after hypoglycemia. Analysis of underlying mechanisms show that the combined action of IGF-I and insulin synergistically stimulates a mitogen-activated protein kinase/protein kinase D pathway resulting in translocation of GLUT1 to the cell membrane through multiple protein-protein interactions involving the scaffolding protein GAIP-interacting protein C terminus and the GTPase RAC1. Our observations identify insulin-like peptides as physiological modulators of brain glucose handling, providing further support to consider the brain as a target organ in diabetes.
Doublecortin (DCX)‐Calretinin (CLR) immunolabeling of the hippocampal dentate gyrus of a 4 month old male mice (Mus musculus). DCX+ (red) and CLR+ (green) neurons in a section from a control (no treatment) mouse, where both DCX+/CLR+ and DCX+/CLR+ can be appreciated. This dual labeling lets to count two different subpopulation of immature, differentiating neurons in two successive stages of maturation with one double immunohistochemistry reaction. Cell counts were performed in these type of sections by using the U‐disector and confocal microscopy. The cover image, by J.L. Trejo et al., is based on the Research Article The relationship between behavior acquisition and persistence abilities: Involvement of adult hippocampal neurogenesis, DOI: .
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.